Deepa Gamage
Overview
Explore the profile of Deepa Gamage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Debellut F, Gamage D, Kumar S, Wickramasinghe S, Ruwanpathirana T, Kariyawasam M, et al.
Vaccine X
. 2024 Feb;
17:100456.
PMID: 38379668
Existing evidence on the cost of human papillomavirus (HPV) vaccination programs has focused on pilot and demonstration projects or initial introductions, which resulted in a perceived high cost. We aimed...
2.
Mvundura M, Slavkovsky R, Debellut F, Naddumba T, Bayeh A, Ndiaye C, et al.
Vaccine
. 2023 Nov;
41(49):7435-7443.
PMID: 37949752
Introduction: There are concerns from immunization program planners about high delivery costs for human papillomavirus (HPV) vaccine. Most prior research evaluated costs of HPV vaccine delivery during demonstration projects or...
3.
Sbarra A, Jit M, Mosser J, Ferrari M, Cutts F, Papania M, et al.
Vaccines (Basel)
. 2023 Aug;
11(8).
PMID: 37631957
A better understanding of population-level factors related to measles case fatality is needed to estimate measles mortality burden and impact of interventions such as vaccination. This study aimed to develop...
4.
Pilic A, Reda S, Jo C, Burchett H, Bastias M, Campbell P, et al.
Vaccine
. 2023 Feb;
41(12):1968-1978.
PMID: 36804216
National immunization technical advisory groups (NITAGs) develop immunization-related recommendations and assist policy-makers in making evidence informed decisions. Systematic reviews (SRs) that summarize the available evidence on a specific topic are...
5.
Jo C, Burchett H, Bastias M, Campbell P, Gamage D, Henaff L, et al.
Vaccine
. 2021 May;
39(23):3103-3110.
PMID: 33965256
National immunization technical advisory groups (NITAGs) develop immunization-related recommendations. Systematic reviews are recommended to be used in this process, but conducting them requires significant resources, which many NITAGs lack. Using...
6.
Spatiotemporal distribution of cutaneous leishmaniasis in Sri Lanka and future case burden estimates
Karunaweera N, Senanayake S, Ginige S, Silva H, Manamperi N, Samaranayake N, et al.
PLoS Negl Trop Dis
. 2021 Apr;
15(4):e0009346.
PMID: 33891608
Background: Leishmaniasis is a neglected tropical vector-borne disease, which is on the rise in Sri Lanka. Spatiotemporal and risk factor analyses are useful for understanding transmission dynamics, spatial clustering and...
7.
Karunaweera N, Ginige S, Senanayake S, Silva H, Manamperi N, Samaranayake N, et al.
Emerg Infect Dis
. 2019 Dec;
26(1):1-10.
PMID: 31855147
Leishmaniasis, a neglected tropical disease, is on the decline in South Asia. However, cases of cutaneous leishmaniasis have risen in Sri Lanka since 2001, and the lack of in-depth research...
8.
Ruwanpathirana T, Senanayake S, Gunawardana N, Munasinghe A, Ginige S, Gamage D, et al.
BMC Public Health
. 2019 Jun;
19(1):763.
PMID: 31200694
Background: Over the last 20 years there have been reports of a form of chronic kidney disease of unknown cause (CKDu) affecting rural communities in the North Central Province of...
9.
Gamage D, Mach O, Ginige S, Weldon W, Oberste M, Jeyaseelan V, et al.
J Infect Dis
. 2019 Jan;
219(12):1887-1892.
PMID: 30649505
Background: In July 2016, Sri Lanka replaced 1 intramuscular dose of inactivated poliovirus vaccine (IPV) with 2 doses of intradermal fractional-dose IPV (fIPV) in its routine immunization schedule. We carried...
10.
Gamage D, Ginige S, Palihawadana P
WHO South East Asia J Public Health
. 2018 Aug;
7(2):79-83.
PMID: 30136665
As part of the Polio eradication and endgame strategic plan 2013-2018 to achieve and sustain a polio-free world, the use of oral polio vaccine (OPV) must eventually be stopped. This...